gynecological cancer
Showing 9976 - 10000 of >10,000
Quantitative FIT Technology in Colorectal Cancer Screening
Recruiting
- Colorectal Cancer Screening Fecal Immunochemical Test
- Quantitative Fecal Immunochemical Test (qFIT)
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Nov 2, 2021
s for Colorectal Cancer of Quantitative FIT in Symptomatic
Recruiting
- Colorectal Cancer
-
Örebro, SwedenSkebäcks VC
Dec 1, 2021
Healthy, no Evidence of Disease, Stage II Breast Cancer, Stage IIIA Breast Cancer Trial in Los Angeles (light-scattering
Terminated
- Healthy, no Evidence of Disease
- +4 more
- light-scattering spectroscopy
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Nov 11, 2021
Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (Irinotecan liposome injection, Folinic Acid, 5-Fluorouracil)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Irinotecan liposome injection
- +2 more
-
Bedford Park, Australia
- +35 more
Jan 24, 2023
Cancer, Type 2 Diabetes Trial in Eltham (Multimodal surgical prehabilitation)
Not yet recruiting
- Cancer
- Type 2 Diabetes
- Multimodal surgical prehabilitation
-
Eltham, England, United KingdomSchool of Human Sciences, University of Greenwich, Avery Hill Ca
Sep 20, 2022
ER+ Breast Cancer, Breast Cancer, Aromatase Inhibitors Trial in Boston (White Wine, Grape Juice)
Not yet recruiting
- ER+ Breast Cancer
- +2 more
- White Wine
- Grape Juice
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 1, 2022
Lymph Node Cancer Metastatic Trial in Hospitalet de Llobregat (Axillary mapping reverse)
Recruiting
- Lymph Node Cancer Metastatic
- Axillary mapping reverse
-
Hospitalet de Llobregat, Barcelona, SpainHospital de Bellvitge
Aug 2, 2022
Cancer Trial in Nyborg (A rehabilition programme for young adult cancer survivors)
Recruiting
- Cancer
- A rehabilition programme for young adult cancer survivors
-
Nyborg, The Region Of Southern Denmark, DenmarkREHPA, The Danish Knowledge Centre for Rehabilitation and Pallia
Sep 20, 2022
Recurrent T Acute Lymphoblastic Leukemia, Refractory T Acute Lymphoblastic Leukemia Trial in United States (AKR1C3-activated
Active, not recruiting
- Recurrent T Acute Lymphoblastic Leukemia
- Refractory T Acute Lymphoblastic Leukemia
- AKR1C3-activated Prodrug OBI-3424
-
Birmingham, Alabama
- +113 more
Jan 24, 2023
Melanoma Trial in Worldwide (Pembrolizumab, Vibostolimab, V937)
Recruiting
- Melanoma
- Pembrolizumab
- +5 more
-
Los Angeles, California
- +28 more
Jan 25, 2023
Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)
Withdrawn
- Carcinoma, Non-small Cell Lung Cancer
- nivolumab
- +5 more
-
Detroit, Michigan
- +22 more
Mar 8, 2022
Cancer, Cancer Pain Trial in Bhaktapur, Kathmandu (Clinical Pharmacist Intervention)
Recruiting
- Cancer
- Cancer Pain
- Clinical Pharmacist Intervention
-
Bhaktapur, Bagmati, Nepal
- +1 more
May 4, 2022
Bladder Cancer Trial in Philadelphia (social incentive-based gamification)
Completed
- Bladder Cancer
- social incentive-based gamification
-
Philadelphia, Pennsylvania
- +1 more
Nov 8, 2022
NSCLC, Metastatic Non Small Cell Lung Cancer, Nsclc Trial in United States (Local ablative therapy, Blood collection to assess
Recruiting
- Non-small Cell Lung Cancer
- +5 more
- Local ablative therapy
- Blood collection to assess for ctDNA
-
Basking Ridge, New Jersey
- +6 more
Jun 20, 2022
Colorectal Cancer, Adenoma Trial in Oslo (A 1 Intervention arm Flex Sig, A 2 Intervention arm Flex Sig + iFOBT)
Active, not recruiting
- Colorectal Cancer
- Adenoma
- A 1 Intervention arm Flex Sig
- A 2 Intervention arm Flex Sig + iFOBT
-
Oslo, NorwayInstitute of Population-based Cancer Research
Apr 6, 2022
Colorectal Cancer Trial in Chengdu (lidocaine, Placebo)
Recruiting
- Colorectal Cancer
- lidocaine
- Placebo
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Jun 24, 2023
SCLC,Extensive Stage Trial in Changchun (AK104 IV infusion;Chiauranib oral)
Not yet recruiting
- SCLC,Extensive Stage
- AK104 IV infusion；Chiauranib oral
-
Changchun, Jilin, ChinaJilin Province Cancer Hospital
Aug 16, 2022
Epithelial Ovarian Cancer Trial in Shanghai (LCAR-M23 cells)
Terminated
- Epithelial Ovarian Cancer
- LCAR-M23 cells
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Aug 15, 2022
Breast Cancer, Stage III Breast Cancer, Breast Cancer Female Trial in Boston (THRIVE, Health Education Support Program)
Not yet recruiting
- Breast Cancer
- +4 more
- THRIVE
- Health Education Support Program
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 8, 2022
NSCLC Trial in Tianjin (Ensartinib, Placebo)
Recruiting
- Non-small Cell Lung Cancer
- Ensartinib
- Placebo
-
Tianjin, ChinaTianJin Medical University Cancer Institute & Hospital
Jul 13, 2022
Breast Cancer Trial in Tianjin (SHR6390+anatrozole)
Recruiting
- Breast Cancer
-
Tianjin, ChinaTianJin Medical University Cancer Institute and Hospital
Apr 6, 2022
HER2 Low and Describe SoC, Treatment Patterns, and Outcome in
Completed
- Breast Cancer
- None (Observational study)
-
Pittsburgh, Pennsylvania
- +12 more
May 25, 2022